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ABSTRACT 
 
Immunohistochemical analysis on cortex-to-cortex heal 
following mandibular vertical ramus osteotomy in 
dynamic condition 
 
 
Jung, Hwi-Dong 
 
 
Department of Dentistry 
The Graduate School, Yonsei University 
 
(Directed by Professor Park, Hyung-Sik, DDS, PhD) 
 
 
Vertical ramus osteotomy (VRO) is a surgical method of performing an osteotomy from the 
sigmoid notch to the postero-inferior border of the ramus from the lateral aspect of the ascending 
ramus for the mandibular setback, followed by healing under dynamic condition which allows 
movement of bony segment. This study aimed to evaluate specific cytokines among the TGF-β 
superfamily at each period following VRO, and to compare those results with fibular fracture heal. 
The 4 beagle dogs were used for this experiments, and euthanized at 1, 2, 4, and 8 weeks 
postoperatively. 6 specific antibodies were used in this immunohistochemical analysis: bone 
morphometric protein -2/4, -7, (BMP -2/4, -7) matrix metalloproteinase-3 (MMP-3), transforming 
growth factor-beta 2, 3 (TGF-ß2, -ß3), and vascular endothelial growth factor (VEGF) 
 iv 
The results are followed:  
1. In VRO heal, inflammatory cell infiltration and resorption of cortical bone at 1 week, 
cartilage formation by chondrocyte at 2 weeks, and cartilage resorption, primary bone 
formation, and vascularization at 4 and 8 weeks were observed in HE staining. In Fibular 
fracture heal, no remarkable differences were seen in HE staining compared to VRO heal at 
each period. 
2. In general upregulation of BMP-2/4 was observed in whole heal periods in VRO and fibular 
fracture, while the strongest expression of BMP-2/4 was observed at 2 weeks postoperative 
following VRO in contrast to a relatively constant expression of BMP-2/4 following fibular 
fracture. 
3. The strongest expression of BMP-7 was observed at 1 week following VRO, in contrast to 
constant up-regulation following fibular fracture. The decreasing pattern in VRO may be 
caused by dynamic movement of mandible. 
4. The strongest expression of TGF-ß2 in VRO was observed at 8 weeks, the expression 
showing increasing pattern, meaning remodeling activity accelerated over time. 
5. Strong expression of TGF-β3 was observed at 1 and 4 weeks in VRO, and at 1 and 8 weeks 
in fibular fracture. Up-regulation at 1 week is explained by degranulation of platelets, and 
up-regulation at 4 weeks in VRO and at 8 weeks in fibular fracture means indicates cartilage 
formation and periosteal response are activated after 4 weeks.  
6. The strong expression of VEGF was observed at 1 week in VRO and 4 and 8 weeks in 
fibular fracture. This result means that the mandibular ramus has sufficient vascularity before 
injury, and that the needs for angiogenesis and vasculogenesis increased later in the case of 
fibular fracture. 
 
 v 
Based on the above findings, the expressions of specific cytokines differed following VRO and 
fibular fracture although the healing process following VRO was similar at each period. Dynamic 
jaw movement is thought to be a contributing factor for differential expression of BMP-7 and 
TGF-β2, and anatomical factors including preexisting vascularity account for differences in 
expression of VEGF. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key words: Vertical ramus osteotomy, Fibular fracture, VRO, Bone healing, TGF-beta 
superfamily 
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I. INTRODUCTION 
  
Vertical ramus osteotomy (VRO) is a surgical technique used for mandibular setback (Akin and 
Walters, 1975; Tornes and Gilhuus Moe, 1987), widely used in Asia because of the high incidence 
there of mandibular prognathism and class III malocclusion (Lew et al., 1993). VRO has several 
advantages over sagittal split ramus osteotomy (SSRO), including a short operation time (Nordin 
et al., 1987), little risk for inferior alveolar nerve damage (Astrand and Ridell, 1973; Hall and 
McKenna, 1987), predictable and reliable postoperative stability (Jung et al., 2013), improvement 
of TMJ symptoms (Bell et al., 1990; Jung et al., 2009), and facilitated rehabilitation of mandibular 
movement postoperatively (Aragon et al., 1985; Boyd et al., 1991; Jung et al., 2012; Storum and 
Bell, 1986). 
Bone healing states after injury are categorized as inflammation, cartilage formation, and 
periosteal response, cartilage resorption and primary bone formation, and secondary bone 
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formation and remodeling. However, none of these include the expression of cytokines, which is 
highly variable and depends on healing stage and biological process (Ai Aql et al., 2008). Unlike 
SSRO, VRO makes a lateral overlap of the proximal segment, immediately changing the position 
of the proximal segment and cortex-to-cortex contact between the segments. The healing process 
takes place in a unique environment that allows free movement of segments; previous studies to 
identify the healing process following VRO are limited to HE staining (Bell and Kennedy, 1976; 
Boyne, 1966; Huebsch and Wellington, 1967).  
When VRO is performed on the mandibular ramus, healing proceeds with cortex-to-cortex 
contact and no internal fixation; we find no cytokine expression studies following cortex-to-cortex 
contact in dynamic condition. Thus, the aim of this study was to analyze and compare expression 
of specific cytokines following VRO, which is considered a dynamic condition, and fibular 
fracture, which is considered a static condition.   
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II. MATERIALS AND METHODS 
 
All experiments were performed under protocols approved by the Institutional Animal Care and 
Use Committee at the CRONEX Co., Ltd (CRONEX-IACUC 201209001). 
 
1. Animal care 
 
 Four 8-month-old male beagle dogs were used in the experiments, average weight 12.57 ± 0.57 
kg (between 11.09 and 13.5 kg). Temperature and relative humidity was maintained at 22 ± 2˚C 
and 50 ± 10%. Air ventilation was done 10 to 15 times per day via 100% HEPA-filter. Illumination 
was maintained at 200 LUX with a contrast period of 12 hours per day (8:00 to 20:00). Noise level 
was adjusted below 40 dB, and the ammonia concentration was less than 20 ppm. Each subject 
was housed in a stainless steel cage (dimensions: 700W x 900D x 1000H (mm); feces were 
cleaned once every morning. The main feedstuff was meat soup, replaced every morning in 
washed bowls. The cage and bowl were cleaned or replaced immediately when contaminated with 
feces. The feeding water was supplied by automatic water nozzles after performing reverse 
osmosis filtering and ultraviolet light irradiation.  
 4 
2. Anesthesia 
 
 2 ml zoletil and xylazine solution (6:4) was injected intravenously before endotracheal intubation; 
isoflurane-induced general anesthesia was maintained during the operation. 
 
3. Vertical ramus osteotomy 
  
 Surgical approach for VRO was performed through extraoral approach. The surgical area was 
sterilized by 10% povidone-iodine solution after shaving and covered with an aseptic surgical 
drape in a conventional manner. Masseter muscle and attached periosteum were reflected after 
submandibular incision (5 cm), then the mandibular inferior border was exposed. The buccal 
aspect of mandibular ramus was dissected until the sigmoid notch was signified. Osteotomy was 
performed with a Stryker reciprocating saw and the osteotomy line was placed posterior to 
ligula to prevent inferior alveolar nerve damage. Anatomically, the coronoid process of dog is 
much bigger than the condylar process, inhibiting mandibular setback. An additional wedge-
shaped ostectomy was thus performed on the sigmoid notch area to facilitate setback of the 
distal segment. Internal fixation was not performed after confirming proper cortex-to-cortex 
contact following mandibular setback (Figure 1). The incised wound was sutured layer by layer. 
The mouth was fixed with a biting roll and elastic bandage to maintain contact between the 
segments (Figure 2). 
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Figure 1. Vertical ramus osteotomy by submandibular approach (A). Distal segment was placed 
lateral to the proximal segment and cortex-to-cortex contact was confirmed (B). 
 
 
Figure 2. Intermaxillary fixation with gauze roll biting and elastic bandage.   
A B 
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4. Fibular fracture 
  
 The right lateral calf was prepared in a sterile manner for artificial fibular fracture. A 3 cm long 
skin incision was performed and dissection was performed until the fibula was identified. 
Periosteum was reflected and oblique osteotomy was performed with reciprocating saw (Figure 3). 
Layer by layer wound closure was done and elastic bandage applied.  
 
 
Figure 3. Displaced segment after fibular fracture.  
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5. Postoperative care and preparation of specimens 
 
 After operation, the subjects received antibiotics (enrofloxacine 0.2 ml/kg, Komipharm 
International Co., Ltd., Korea), administered intramuscularly for 3 days to prevent postoperative 
infection. Elastic bandage was applied for 7 days as well as a neck collar to prevent loosening the 
bandage by front foot. The bandage was removed at 8
th
 day postoperatively and solid feed was 
mixed to water for feeding. The subjects were euthanized with suxamethonium chloride hydrate 50 
mg/kg (Komipharm International Co., Ltd., Korea) intravenous injection at 1, 2, 4, and 8 weeks 
postoperatively. The experimental specimens were carefully harvested en bloc including their 
adjacent soft tissue, then fixed with 10% paraformaldehyde for 2 weeks. 0.5 mol EDTA was used 
for decalcification, the solution being changed every week.  
 
6. Immunohistochemistry 
 
IHC staining was performed on 6 μm paraffin-embedded sections. The sections were treated by 
heat-induced epitope retrieval with citrate buffer pH6.0 (Invitrogen). The slides were incubated 
with antibodies against VEGF (1:200 diluted, sc-507, Santa Cruz, USA), BMP7 (1:200 diluted, sc-
9032, Santa Cruz, USA), MMP3 (1:200 diluted, sc-6839, Santa Cruz, USA), TGFβ2 (1:200 diluted, 
sc-90, Santa Cruz, USA), TGFβ3 (1:60 diluted, MAB243, R&D systems, USA), or BMP-2/4 
(1:100 diluted, sc-9003, Santa Cruz, USA) at 4 °C overnight. The specimens were sequentially 
incubated with secondary antibody and streptavidin peroxidase. Finally, the results were visualized 
following staining using a diaminobenzidine (DAB) reagent kit (Invitrogen, USA). The sections 
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were counterstained with Mayer’s hematoxylin. All specimens were observed by stereomicroscope 
(MD5500D; Leica, camera: DFC495; Leica, Lens: HCX PL APO 409; Leica). The positive pixels 
of images were counted using the software Leica Application to evaluate IHC staining (Leica 
Microsystems, Germany). All parameters of image acquisition were kept the same to allow 
accurate comparison. 
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III. RESULTS 
 
1. VRO (HE staining) 
 
Inflammatory cell infiltration and resorption of cortical bone was seen 1 week postoperatively. 
Cartilage formation by chondrocyte was observed at 2 weeks. Cartilage resorption, primary bone 
formation, and vascularization was observed at 4 weeks, and the process of maturing was 
maintained 8 weeks postoperatively. 
 
 
Figure 4. Vertical ramus osteotomy, HE staining. 
A. 1 week, B. 2 weeks, C. 4 weeks, and D. 8 weeks postoperatively.  
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2. VRO (Immunohistochemical analysis) 
 
Six antibodies including bone morphogenetic protein-2/4, -7 (BMP-2/4, -7), matrix 
metalloproteinase-3 (MMP-3), transforming growth factor-beta 2, 3 (TGF-ß2, -ß3), and vascular 
endothelial growth factor (VEGF) were used for immunohistochemistry. Expression results are 
followed by figures. 
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A. BMP-2/4 
 
Figure 5. Expression of BMP-2/4 following VRO. 
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
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B. BMP-7 
 
Figure 6. Expression of BMP-7 following VRO. 
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
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C. MMP-3 
 
Figure 7. Expression of MMP-3 following VRO. 
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
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D. TGF-β2 
 
Figure 8. Expression of TGF-ß2 following VRO.  
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
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E. TGF-β3 
 
Figure 9. Expression of TGF-ß3 following VRO.  
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
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F. VEGF 
 
Figure 10. Expression of VEGF following VRO. 
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
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3. Fibular fracture (HE staining) 
 
Inflammatory cell infiltration and resorption of cortical bone was seen 1 week postoperatively. 
Cartilage formation by chondrocyte was observed at 2 weeks. Cartilage resorption, primary bone 
formation, and vascularization were observed at 4 weeks, and the process of maturing was 
maintained 8 weeks postoperatively. One segment was removed while making slides of 1 and 2 
week samples. 
 
 
Figure 11. Fibular fracture, HE staining. 
A. 1 week, B. 2 weeks, C. 4 weeks, and D. 8 weeks postoperatively.  
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4. Fibular fracture (immunohistochemical analysis) 
 
Six antibodies including bone morphogenetic protein-2/4, -7 (BMP-2/4, -7), matrix 
metalloproteinase-3 (MMP-3), transforming growth factor-beta 2, 3 (TGF-ß2, -ß3), and vascular 
endothelial growth factor (VEGF) were used for immunohistochemistry. Expression results are 
followed by figures. 
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A. BMP-2/4 
 
Figure 12. Expression of BMP-2/4 following fibular fracture. 
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
 20 
B. BMP-7 
 
Figure 13. Expression of BMP-7 following fibular fracture. 
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
 21 
C. MMP-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Expression of MMP-3 following fibular fracture.  
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
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D. TGF-β2 
 
Figure 15. Expression of TGF-ß2 following fibular fracture.  
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively.  
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E. TGF-β3 
 
Figure 16. Expression of TGF-ß3 following fibular fracture.  
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively. 
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F. VEGF 
 
Figure 17. Expression of VEGF following fibular fracture.  
A, B. 1 week, C, D. 2 weeks, E, F. 4 weeks, and G, H. 8 weeks postoperatively. 
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5. Evaluation of immunohistochemical analysis 
 
The positive pixels of images were counted using the software Leica Application to evaluate IHC 
staining (Leica Microsystems, Germany). The strongest expression of BMP-2/4 was observed at 2 
weeks postoperatively in VRO, a relatively constant expression of BMP-2/4 being observed in 
fibular fracture. A decreased pattern of BMP-7 was observed in VRO, significant down-regulation 
being observed at 4 and 8 weeks postoperatively. In contrast to VRO, the expression pattern of 
BMP-7 was constant in fibular fracture. An increased pattern of TGF-β2 was observed in VRO, the 
expression pattern remaining constant in fibular fracture. Up-regulation of TGF-β3 was observed 
at 1 and 4 weeks in VRO, and at 1 and 8 weeks in fibular fracture. A decreased pattern of 
expression of VEGF was observed in VRO, up-regulation of VEGF being observed at 1 week in 
VRO, and at 4 and 8 weeks in fibular fracture. The results showed in figure 18 and 19. 
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Figure 18. Evaluation of IHC staining in VRO. 
 
 
Figure 19. Evaluation of IHC staining in fibular fracture. 
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IV. DISCUSSION 
  
The healing process following orthognathic surgery is based on the substantial capacity of bone 
for repair and regeneration in response to injury. Orthognathic surgery corrects conditions of the 
jaw and face related to structure, growth, sleep apnea, TMJ disorders, malocclusion problems 
owing to skeletal disharmonies, or other orthodontic problems that cannot be easily treated with 
braces. VRO is a surgical method for mandibular setback performed as vertical osteotomy from 
sigmoid notch to mandibular angle while avoiding the mandibular foramen. Conventionally, 
internal fixation is not performed following VRO, thus bone heal following VRO is considered 
secondary bone healing allowing dynamic movement of bony segments. The aim of this study was 
to determine the specific signaling molecules in each period following VRO and to compare the 
results with those from fibular fracture, which is considered a relatively static condition. 
Bone repair in adults recapitulates the pathway of embryonic development, with the coordinated 
participation of several cell types originating from the cortex, periosteum, surrounding soft tissue, 
and bone marrow (Ferguson et al., 1999; Gerstenfeld et al., 2003). The majority of fractures heal 
through a combination of intramembranous and endochondral ossification. Endochondral bone 
formation usually occurs external to the periosteum, around the fractured site, whereas 
intramembranous ossification occurs internal to the periosteum at the proximal and distal edges 
(Dimitriou et al., 2005). Cortex-to-cortex contact is made following VRO, and bony gap also 
remains in fibular fracture, thus endochondral bone formation might be the main process in 
healing. The most important difference was mobility status; although dynamic movement was 
allowed by jaw movement in VRO, fibular fracture was relatively static because the fibula is not a 
weight-bearing bone. 
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Bone healing is categorized in terms of inflammation, cartilage formation and periosteal response, 
cartilage resorption and primary bone formation, and secondary bone formation and remodeling. In 
this study, no remarkable difference in HE staining was observed between VRO and fibular fracture. 
The histologic pattern observed was inflammatory phase in 1 week; cartilage formation and 
periosteal response in 2 weeks; and cartilage resorption and primary bone formation in 4 and 8 weeks. 
Inflammatory cytokines are produced and function immediately after injury for a limited time 
period, initiating the repair cascade following injury. Interleukins-1 and -6 (IL-1 and IL-6) and 
tumor necrosis factor-alpha (TNF-α) have been shown to play a role in initiating the repair cascade. 
They are secreted at the injury site by macrophages, inflammatory cells, and cells of mesenchymal 
origin, their expression peaking within the first 24 hours and then declining rapidly (Cho et al., 
2002). They induce a downstream response to injury by recruiting other inflammatory cells, 
enhancing extracellular matrix synthesis, and stimulating angiogenesis (Kon et al., 2001). 
The TGF-β superfamily consists of a large number of growth and differentiation factors that 
include BMPs, TGF-β, GDFs, activins, inhibins, and Müllerian inhibiting substance. Among them, 
BMPs (2-8), GDF (1,5,8, and 10), and TGF-β 1-3 specifically promote various stages of 
intramembranous and endochondral bone ossification during bone healing (Cho et al., 2002). 
Different BMPs act to trigger a cascade of events that promote the formation of cartilage or bone, 
functioning independently or in collaboration with each other as well as with other members of the 
TGF-β superfamily. BMPs are produced by mesenchymal cells, osteoblasts, and chondrocytes. 
Cellular processes stimulated include chemotaxis, mesenchymal cell proliferation and 
differentiation, angiogenesis, and synthesis of extracellular matrix (Reddi, 2001; Sakou, 1998). 
BMP-2 is known as an initiator of the repair cascade and a controller for the expression of several 
other BMPs. It is known as an essential element for postnatal bone repair and is genetically 
associated with the maintenance of normal bone mass (Tsuji et al., 2006; Xiong et al., 2006). 
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When its activity is blocked, marrow stromal stem cells fail to differentiate into osteoblasts (Edgar 
et al., 2007). Up-regulation of BMP-2 and -4 are observed in whole bone healing steps including 
inflammation; cartilage formation and periosteal response; cartilage resorption and primary bone 
formation; and secondary bone formation and remodeling (Cho et al., 2002; Dimitriou et al., 2005; 
Gerstenfeld et al., 2003; Kon et al., 2001). In this study, the strongest expression of BMP-2/4 was 
observed at 2 weeks postoperatively in VRO, whereas relatively continuous up-regulation was 
observed in fibular fracture.  
BMP-7 plays a key role in the transformation of mesenchymal cells into bone and cartilage (Chen 
et al., 2004). Cho et al. reported that BMP-7 shows a restricted period (days 14 through 21) of 
expression during fracture healing, when the resorption of calcified cartilage and osteoblastic 
recruitment are the most active in murine experiment (Cho et al., 2002). In our results, the 
strongest expression of BMP-7 was observed at 1 week in VRO, then decreasing. However, a 
constant expression pattern was observed in fibular fracture. Tsuji et al. reported that the absence 
of locally produced BMP-7 has no effect on postnatal bone growth, articular cartilage formation, 
maintenance of bone mass, or fracture heal (Tsuji et al., 2006). Weak or nearly absent expression 
of BMP-7 was observed during distraction osteogenesis (Campisi et al., 2003; Sato et al., 1999; 
Yazawa et al., 2003). Thus, dynamic movement between bony segments may lead to decreased 
expression of BMP-7 following VRO.  
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of 
extracellular matrix and during tissue remodeling in normal physiological processes. Further, 
MMP-3 can activate other MMPs such as MMP-1, -7, and -9, rendering MMP-3 crucial in 
connective tissue remodeling (Ye et al., 1996). In our results, up-regulation of MMP-3 was 
observed at weeks 1 and 4 in VRO, the strongest expression following fibular fracture being 
observed at 2 weeks post-operative. 
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TGF-β1-3 are produced by degranulated platelets after initial injury, which suggests their 
involvement in the initiation of callus formation (Bolander, 1992; Bostrom, 1998). They are 
also produced by osteoblasts and chondrocytes at later stages, enhancing the proliferation of 
these cells as well as that of mesenchymal cells and pre-osteoblasts (Lieberman et al., 2002). 
TGF-β, thought to play an important role in chondrogenesis and endochondral bone formation 
(Barnes et al., 1999), induces the expression of extracellular matrix proteins (Sandberg et al., 
1993). In our results, the strongest expression of TGF-ß2 was observed at 8 weeks in VRO 
with increased pattern. Up-regulated expression was observed at weeks 1, 2, and 8 in fibular 
fracture. TGF-β2 functions as a local positive regulator of bone remodeling (Erlebacher and 
Derynck, 1996); Erlebacher et al. observed overexpressed TGF-β2 at the site of matured bone 
matrix formation, which is suspected to be a homeostatic response to increased bone resorption 
(Erlebacher et al., 1998). Thus, we can conclude that the remodeling activity is accelerated 
under dynamic condition following VRO based on the increase pattern of BMP-7 in VRO. 
Further, the strong expression of TGF-β3 at 1 week in VRO and fibular fracture may be caused 
by degranulated platelets, and the up-regulation at 4 weeks in VRO and at 8 weeks in fibular 
fracture may be caused by activation of the remodeling response (Cho et al., 2002; Dimitriou et 
al., 2005).  
Optimal bone healing is dependent on adequate vascularization and therefore requires the 
development of new blood vessels; VEGF is a signal protein produced by cells that stimulates 
vasculogenesis and angiogenesis. In this study, the strong expression of VEGF was observed at 1 
week in VRO, and at 4 and 8 weeks in fibular fracture. The different patterns of up-regulation 
might be due to an anatomical factor: whereas the mandibular ramus has relatively greater blood 
flow than do extremities, the need for vasculogenesis and angiogenesis is greater in late stage 
following fibular fracture. 
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To achieve stable bone healing after VRO, one must understand the bone healing mechanism. In 
the present study, significantly different expression patterns were observed with respect to BMP-7, 
TGF-β2, and VEGF. Dynamic movement following VRO is strongly suspected as a factor for a 
decrease expression pattern of BMP-7, and BMP-7 might not be an essential factor for bone 
healing. The increase expression pattern of TGF-β2 means that the remodeling activity is 
accelerated over time following VRO. Moreover, sufficient preexisting vascularity in the 
mandibular ramus accounts for the earlier expression of VEGF in VRO.  
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V. CONCLUSION 
 
Vertical ramus osteotomy (VRO) is a surgical method of performing an osteotomy from the 
sigmoid notch to the postero-inferior border of the ramus from the lateral aspect of the ascending 
ramus for the mandibular setback, followed by healing under dynamic condition which allows 
movement of bony segment. This study aimed to evaluate specific cytokines among the TGF-β 
superfamily at each period following VRO, and to compare those results with fibular fracture heal. 
The 4 beagle dogs were used for this experiment were euthanized at 1, 2, 4, and 8 weeks 
postoperatively. 6 specific antibodies were used in this immunohistochemical analysis: bone 
morphogenetic proteins -2/4, -7 (BMP -2/4, -7), matrix metalloproteinase-3 (MMP-3), 
transforming growth factor-beta 2, 3 (TGF-ß2, -ß3), and vascular endothelial growth factor 
(VEGF). 
The results are as follows:  
 
1. In VRO heal, inflammatory cell infiltration and resortion of cortical bone at 1 week, cartilage 
formation by chondrocyte at 2 weeks, and cartilage resorption, primary bone formation, and 
vascularization at 4 and 8 weeks were observed in HE staining. In fibular fracture heal, no 
remarkable differences were seen in HE staining compared to VRO heal at each period. 
2. In general, upregulation of BMP-2/4 was observed in whole heal periods in VRO and fibular 
fracture, while the strongest expression of BMP-2/4 was observed at 2 weeks postoperative 
following VRO in contrast to a relatively constant expression of BMP-2/4 following fibular 
fracture. 
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3. The strongest expression of BMP-7 was observed at 1 week following VRO, in contrast to 
constant up-regulation following fibular fracture. The decreasing pattern in VRO may be 
caused by dynamic movement of mandible. 
4. The strongest expression of TGF-ß2 in VRO was observed at 8 weeks, the expression 
showing increasing pattern, meaning remodeling activity accelerated over time. 
5. Strong expression of TGF-β3 was observed at 1 and 4 weeks in VRO, and at 1 and 8 weeks 
in fibular fracture. Up-regulation at 1 week is explained by degranulation of platelets, and 
up-regulation at 4 weeks in VRO and at 8 weeks in fibular fracture indicates cartilage 
formation and periosteal response are activated after 4 weeks.  
6. The strong expression of VEGF was observed at 1 week in VRO and 4 and 8 weeks in 
fibular fracture. This result means that the mandibular ramus has sufficient vascularity before 
injury, and that the need for angiogenesis and vascular genesis increased later in the case of 
fibular fracture. 
 
Based on the above findings, the expressions of specific cytokines differed following VRO and 
fibular fracture although the healing process following VRO was similar at each period. Dynamic 
jaw movement is thought to be a contributing factor for differential expression of BMP-7 and 
TGF-β2, and anatomical factors including preexisting vascularity account for differences in 
expression of VEGF.   
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ABSTRACT (IN KOREAN) 
 
비고정성 하악골 상행지 수직 골절단술에서의 피질골
간 접촉 치유에 관한 면역형광염색 연구 
 
<지도교수 박 형 식> 
연세대학교 대학원 치의학과 
정 휘 동 
 
하악골 상행지 수직 골절단술 (Vertical ramus osteotomy, VRO)은 Sigmoid notch로
부터 상행지 후하방까지 수직 골절단술을 시행하는 술식으로 하악골 후퇴에 주로 이
용되는 악교정 수술 기법이다. VRO 시행 후 근심골편은 원심 골편의 외측에 위치되
어 피질골간 접촉이 형성되며, 골편간 고정이 시행되지 않고 능동적 움직임이 허용되
는 독특한 환경에서 치유가 진행된다. 본 연구의 목적은 VRO 후 치유과정에서 나타
나는 특정 cytoknoe의 변화 양상을 면역형광염색을 통해 관찰하고, 비골골절에서 
VRO와 동일한 비고정, 피질골간 접촉 조건 하의 치유과정과의 차이를 규명하고자 함이
다. 총 4 마리의 비글견을 이용하여 연구를 진행하였으며 각각의 개체에서 구외접근을 
통한 VRO와 비골 골절 후 각각 1, 2, 4, 8 주에 희생하여 조직을 적출하였다. 각각의 
시기에 cytokine의 발현을 확인하기 위하여 6개의 특정 항체를 이용한 면역형광염색을 
시행하였다: Bone morphometric protein-2/4, -7, (BMP-2/4, -7) matrix 
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metalloproteinase-3 (MMP-3), transforming growth factor-beta 2, 3 (TGF-ß2, -ß3), 
and vascular endothelial growth factor (VEGF). 면역형광염색 결과는 Leica 
application을 이용하여 positive pixel counting을 시행하여 발현 정도를 평가하였다. 
상기 연구 과정을 통하여 아래와 같은 결과를 얻었다. 
1. VRO와 비골골절의 치유 양상은 HE 염색상 유사한 과정을 보였다. 염증세포 침
윤 및 피질골의 파괴가 1주 경과 시 관찰되었으며, 연골형성이 2주에 관찰되었
고, 연골 흡수, 일차 골형성, 혈관형성이 4주, 8주에서 관찰되었다. 
2. BMP-2/4의 발현은 양측 모두에서 모든 시기에 나타났다. VRO의 경우 가장 강
한 발현은 술후 2주에 나타났으며, 비골골절에서는 비교적 일정한 발현이 지속
되는 양상으로 관찰되었다. 
3. BMP-7의 발현은 양측에서 다른 양상으로 관찰되었다. VRO의 경우 술후 1주에 
가장 강한 발현을 보이고 이후 점차 감소하는 양상을 보였으며, 비골골절에서는 
비교적 일정한 정도의 발현이 지속되는 양상이 관찰되었다. VRO 후 허용되는 능
동적 움직임이 BMP-7의 발현 감소의 원인으로 생각되었다. 
4. TGF-β2의 발현은 양측에서 다른 양상으로 관찰되었다. VRO의 경우 점차 발현
이 증가하는 양상을 보였으나, 비골골절에서는 특정한 패턴을 관찰할 수 없었다. 
VRO 후 발현이 증가하는 이유는 능동적 움직임에 기인한 것으로 판단되며, 시
간이 경과할수록 골재형성이 가속화되는 것으로 판단되었다. 
5. TGF-β3의 경우 VRO 에서는 1주, 4주의 시기에 가장 강한 발현을 보였으며, 비
골 골절의 경우 1주, 8주의 시기에 가장 강한 발현을 나타냈다. 1주의 강한 발현
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은 혈소판 탈과립화에 의한 것으로 판단되며, 4주 이후의 강한 발현은 골 재형성
화에 기인한 것으로 생각되었다. 
6. VEGF의 발현은 양측에서 다른 양상으로 관찰되었다. VRO에서는 1주에 강한 발
현을 보였고 이후 감소된 채 유지되는 양상을 보였으며, 비골골절에서는 4주와 
8주에 발현이 증가하는 양상을 보였다. 이는 해부학적으로 하악골 상행지의 혈
행이 상대적으로 양호하여 술 후 1주를 제외하고 혈관 신생의 요구도가 낮고, 
비골에서는 혈행이 상대적으로 불량하여 4주 이후 혈관 신생의 요구도가 높았기 
때문으로 판단된다. 
 
이상의 결과를 바탕으로 VRO와 비골골절 후 HE 염색상 각각의 시기에서 양측의 
차이는 관찰되지 않음을 확인할 수 있었으며, 각각의 시기에 특정 cytokine의 발현
은 차이를 보임을 확인할 수 있었다. BMP-7의 감소경향은 VRO후 허용되는 능동적 
움직임에 기인한 독특한 양상으로 판단되었으며, TGF-β2의 증가경향은 VRO후 시
간이 경과할수록 골재형성화가 가속화됨을 의미한다. 또한, VRO에서 1주에서만 나
타난 VEGF의 강한 발현은 하악골 상행지의 혈행이 비골보다 유리했기 때문으로 판
단되었다.  
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